BioSpace News Archive

Medical Experts Suggest an Alarming Rise in Lung Cancer in Non-Smokers in the UAE

There are an estimated 150 cases of lung cancer per year in the UAE,around 40 – 50 percent of these cases are at an advanced mostly incurable stage

December 12, 2018
·
3 min read
Streamlining the workflow with INTEGRA’s VIAFLO 96/384

Researchers at the University of Zurich in Switzerland are using INTEGRA’s VIAFLO 96/384 multichannel electronic pipette to streamline the experimental workflow of studies on Pseudomonas aeruginosa – a bacterium that commonly infects individuals with lung conditions, such as cystic fibrosis.

December 12, 2018
·
2 min read
Deals

In Stalking Horse Bid, Bausch Health Buys Synergy Pharma’s Assets

Bausch Health Companies is acquiring basically all of Synergy Pharmaceuticals’ assets, including all rights to Trulance (plecanatide), dolcanatide and related intellectual property.

December 12, 2018
·
2 min read
·
Mark Terry
Medtronic Named One of America’s Best Corporate Citizens in 2018 by Forbes Magazine

Medtronic plc today announced it has been named one of America’s Most JUST Companies in 2018, according to Forbes magazineand JUST Capital, a nonprofit that ranks publicly-traded corporations on the issues Americans care about most.

December 12, 2018
·
4 min read
Outcomes of weight loss surgery can be improved

Lower BMI before bariatric surgery predicts greater post-operative weight loss, a new study from the University of Eastern Finland finds.

December 12, 2018
·
3 min read
Business

Lilly and AC Immune Sign Deal to Develop Tau-Based Treatments for Alzheimer’s

Eli Lilly and Company, headquartered in Indianapolis, and AC Immune SA, based in Lausanne, Switzerland, entered a license and collaboration deal to research and develop tau aggregation inhibitor compounds for the treatment of Alzheimer’s and other neurodegenerative diseases.

December 12, 2018
·
2 min read
·
Mark Terry
FDA

FDA Rejects Mallinckrodt’s Abuse-Deterrent Opioid Painkiller

The rejection comes about a month after the painkiller was cleared by an FDA advisory committee.

December 12, 2018
·
2 min read
·
Alex Keown
Policy

FDA Expands on Biologics and Biosimilars Action Plan, Especially for Diabetes Products

Yesterday, the agency and Gottlieb doubled-down on the Action Plan and added to it. The FDA released two new draft Q&A guidance documents on biosimilar development and two final guidance documents on the same topics, as well as a proposed amendment to the definition of a biological product.

December 12, 2018
·
3 min read
·
Mark Terry
Policy

Lawsuit Charges FDA, NIH With Failing to Follow Established Law for Reporting of Clinical Trial Data

The lawsuit alleges that the government is letting a number of researchers off the hook of reporting clinical data.

December 12, 2018
·
2 min read
·
Alex Keown
Deals

Edison initiates coverage of ADL Bionatur Solutions forecasting an equity valuation of EUR 2.37 per share with an upside potential of 42%

Potential upside of more than 42% compared to MAB closing price of EUR 1.66 on 10 December 2018

December 12, 2018
·
3 min read